Medicine and Dentistry
Symptomatic Treatment
100%
Geriatric Assessment
37%
Telehealth
28%
Clinician
26%
Malignant Neoplasm
22%
Systematic Review
21%
Patient Referral
18%
Aged Care
15%
End of Life Care
14%
Oncology
14%
Randomized Controlled Trial
14%
Geriatrics
14%
Physician
14%
Myelodysplastic Syndrome
14%
Geriatric Oncology
14%
Erythrocyte Transfusion
12%
Cross Sectional Study
11%
Hospital Inpatient
10%
Dyspnea
10%
Prevalence
9%
Adverse Event
8%
Medicine
8%
Community-Based Palliative Care
8%
Blood Transfusion
8%
Supportive Care
8%
Karnofsky Performance Status
7%
Comorbidity
7%
Parasympatholytic
7%
Diseases
7%
Upper Limb
7%
Treatment Duration
7%
Hip Fracture
7%
Nursing Home
7%
Clinical Observation
7%
Infancy
7%
Advanced Cancer
7%
Nausea
7%
Azacitidine
7%
Health Care Utilization
7%
Community Pharmacy
7%
Oncologist
7%
Chronic Obstructive Pulmonary Disease
7%
Off-Label Use
7%
Retrospective Cohort Study
7%
Palliative Care Population
7%
Health Services Research
7%
Endorphin
7%
Palliative Medicine
7%
Antiemetic
6%
Opioid Receptor
5%
Nursing and Health Professions
Palliative Therapy
60%
Telehealth
24%
Advance Care Planning
15%
Tertiary Care Center
14%
Hospital Inpatient
14%
Geriatric Assessment
14%
Systematic Review
14%
Self Report
12%
Malignant Neoplasm
12%
Nausea
11%
Patient Referral
10%
Prevalence
9%
General Practitioner
9%
Community-Based Palliative Care
8%
Physician
7%
Health Care Personnel
7%
Pilot Study
7%
Umbrella Review
7%
Teaching Hospital
7%
Nursing Home
7%
Hospice Population
7%
Telemonitoring
7%
Hospital Setting
7%
Health Care
7%
Dyspnea
7%
Aged Care
7%
Symptom Assessment
7%
Palliative Care Population
7%
Terminal Care
7%
Pharmaceutical Care
7%
4 (para chlorophenyl) 1 [3 (para fluorobenzoyl)propyl] 4 piperidinol
5%
Antiemetic Agent
5%
Pharmacology, Toxicology and Pharmaceutical Science
Myelodysplastic Syndrome
14%
Antiemetic Agent
10%
Cholinergic Receptor Blocking Agent
10%
Randomized Controlled Trial
8%
Comorbidity
7%
Nausea
7%
Dyspnea
7%
4 (para chlorophenyl) 1 [3 (para fluorobenzoyl)propyl] 4 piperidinol
7%
Advanced Cancer
7%
Azacitidine
7%
Pharmacovigilance
7%
Chronic Obstructive Lung Disease
7%
Endorphin
7%
Pruritus
7%
Community Pharmacy
7%
Opiate Receptor
5%
Metoclopramide
5%
Diseases
5%